StockNews.AI
LIVN
StockNews.AI
210 days

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

1. LivaNova will announce Q4 and FY 2024 earnings on February 25, 2025. 2. Conference call to begin at 1 p.m. London time, 8 a.m. Eastern. 3. Recent focus on neurological and cardiac technologies impacts growth prospects. 4. Company has a strong global presence in over 100 countries. 5. Forward-looking statements highlight strategic plans and possible risks.

4m saved
Insight
Article

FAQ

Why Bullish?

LivaNova's earnings call could reveal positive growth metrics, influencing investor sentiment.

How important is it?

The earnings release and call are critical for assessing LivaNova's financial health.

Why Short Term?

Upcoming earnings announcement could lead to immediate market reactions, similar to past results.

Related Companies

LIVN
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2024 results prior to the call. The audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the U.S.) or +1 929 526 1599 (if dialing from outside the U.S.). The conference call access code is 982570. A replay will be available on the LivaNova website for 90 days following the call. About LivaNova LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals, and healthcare systems worldwide. For more information, please visit www.livanova.com. Safe Harbor Statement This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the next Company conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

Related News